Northrop Grumman Corporation — FY2022 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. The filing is an annual report, not a standalone fourth-quarter filing. Northrop Grumman is a global aerospace and defense company organized into Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The U.S. government represented 86% of 2022 sales.
Financial performance and position
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Sales | $36.602 billion | $35.667 billion | Up 3% |
| Operating income | $3.601 billion | $5.651 billion | Down 36% |
| Operating margin | 9.8% | 15.8% | Down 600 basis points |
| Net earnings | $4.896 billion | $7.005 billion | Down 30% |
| Diluted EPS | $31.47 | $43.54 | Down 28% |
| Transaction-adjusted EPS | $25.54 | $25.63 | Approximately flat |
| Cash from operations | $2.901 billion | $3.567 billion | Down 19% |
| Adjusted free cash flow | $1.621 billion | $2.236 billion | Down 28% |
| Cash and equivalents | $2.577 billion | $3.530 billion | Down $953 million |
| Long-term debt | $12.877 billion | $12.783 billion | Higher by $94 million |
| Backlog | $78.743 billion | $76.046 billion | Up 4% |
Reported earnings benefited from a $1.232 billion mark-to-market pension and other postretirement benefit gain, compared with a $2.355 billion gain in 2021. Reported 2021 results also included a $1.980 billion pretax gain from the 2021 IT services divestiture. Excluding divestiture-related items and pension mark-to-market effects, transaction-adjusted net earnings declined 4% to $3.974 billion.
Capital expenditures were $1.435 billion. The company paid $1.052 billion in dividends and repurchased $1.504 billion of common stock. The quarterly dividend was increased 10% to $1.73 per share in May 2022. Approximately $2.6 billion remained available under share repurchase authorizations at year-end.
Segment performance
| Segment | 2022 sales | Sales change | 2022 operating margin |
|---|---|---|---|
| Aeronautics Systems | $10.531 billion | Down 6% | 10.6% |
| Defense Systems | $5.579 billion | Down 3% | 11.9% |
| Mission Systems | $10.396 billion | Up 3% | 15.6% |
| Space Systems | $12.275 billion | Up 16% | 9.4% |
Space Systems drove growth through higher activity on GBSD, Next Generation Interceptor, Space Development Agency, and Commercial Resupply Services programs. Aeronautics Systems sales declined due to lower volume on restricted programs, Global Hawk, E-2, and JSTARS. Space Systems margin declined because of lower favorable estimate-at-completion adjustments and a $45 million commercial inventory write-down, partially offset by a $96 million land-exchange gain.
Material changes and unusual items
- Sales increased $935 million, while organic sales increased approximately $1.1 billion, or 3%.
- Operating income declined primarily because 2021 included the $2.0 billion IT services divestiture gain and related items. The 2022 FAS/CAS operating adjustment was also $330 million lower.
- Net estimate-at-completion adjustments declined to $360 million from $527 million, reflecting inflationary and supply-chain pressures.
- The company recorded a $1.232 billion pension and other postretirement mark-to-market benefit, largely from a 256-basis-point increase in the discount rate, partly offset by a 15.4% decline in plan assets.
- Cash flow was reduced by approximately $900 million of federal tax payments associated with the IRC Section 174 requirement to amortize research and development expenditures.
- The company won approximately $39.3 billion of net awards in 2022, including $10.6 billion for restricted programs, $5.3 billion for F-35, $2.1 billion for GEM63 boosters, and $1.5 billion for SDA Tranche 1 programs.
Liquidity, debt, and commitments
Northrop Grumman reported $2.577 billion of cash and no borrowings under its $2.5 billion revolving credit facility or commercial paper program at December 31, 2022. It also maintained a renewed $500 million uncommitted credit facility. Management expects cash, operating cash flow, and available financing sources to provide sufficient short- and long-term liquidity.
- Purchase obligations: $19.0 billion, approximately half short-term.
- Capital expenditure commitments: $1.5 billion.
- Unrecognized tax benefits: approximately $1.7 billion, including $543 million related to IRC Section 451(b).
- Environmental remediation accrued costs: $565 million, with $353 million of reasonably possible future costs in excess of accrued amounts.
- Standby letters of credit and guarantees: $373 million; surety bonds: $77 million.
Outlook, commentary, and principal risks
Management expects the challenging macroeconomic environment, including inflation, labor constraints, supply-chain disruption, and higher interest rates, to continue affecting the company and industry in 2023. Management believes heightened global security concerns, the Ukraine conflict, and defense priorities in Europe and the Pacific could support long-term demand, particularly for space, C4ISR, missile defense, advanced weapons, and survivable aircraft.
- B-21 LRIP exposure: The company believes it is reasonably possible that one or more of the five low-rate initial production options could be loss-making. The estimated aggregate potential loss ranges from $0 to $1.2 billion; no loss was recorded because management did not consider a loss probable at year-end.
- Government funding: Continuing resolutions, appropriations delays, a government shutdown, or a debt-ceiling breach could delay programs, payments, and new starts.
- Contract risk: Approximately 49% of sales were from fixed-price contracts, exposing the company to cost growth, particularly on development and low-rate production programs.
- Investigations: The DOJ issued a criminal subpoena concerning financial and cost accounting controls and interest-rate assumptions used for CAS pension expense. The company cannot predict the outcome or estimate any potential loss.
- Environmental matters: Bethpage, New York remediation and related litigation could require additional costs beyond current estimates.
- Customer concentration: Dependence on the U.S. government exposes results to changes in defense priorities, appropriations, procurement decisions, and contract termination or modification.
- Operational risks: Cybersecurity threats, supplier viability, microelectronics availability, labor shortages, technical performance, launch failures, and geopolitical developments could affect costs, schedules, and profitability.
- Tax and pension volatility: Tax audits, uncertain tax positions, pension asset performance, discount rates, and actuarial assumptions may materially affect cash flow and earnings.
Investor verification checklist
- Verify the sustainability of reported earnings using transaction-adjusted results and excluding pension mark-to-market benefits.
- Monitor B-21 LRIP cost estimates, contract negotiations, supplier performance, and any transition from reasonably possible to probable losses.
- Review operating cash conversion, the effect of IRC Section 174 tax payments, working-capital trends, and future capital expenditures.
- Assess backlog quality by separating funded backlog of $32.491 billion from unfunded backlog of $46.252 billion and considering expected conversion timing.
- Track the DOJ and DCMA pension-cost matters, related reserves, and any effect on government contract recoveries.
- Evaluate exposure to U.S. government budget decisions, fixed-price contract cost growth, inflation, labor availability, and supply-chain constraints.
- Review Bethpage environmental liabilities and related personal-injury, property-damage, insurance, and governmental claims.
- Confirm debt maturities, including $1.072 billion due in 2023 and $1.521 billion due in 2025, against projected cash generation and capital allocation.